In this edition:
Leukotriene inhibitor's effect on post-traumatic osteoarthritis
Impacts of social determinants of health and the immune system in acute and chronic LBP
Is gout a gateway to chronic opioid use?
Variations in approach to the diagnosis and management of PMR
The potential of an oral TNFα inhibitor with TNFR1 specificity
Microbiome transplantation prevents osteoarthritis in mice
Non-TNFi disease-modifying/targeted synthetic DMARDs vs TNFi in RA-ILD
Comparison of two dosing schedules for oral methotrexate for RA
Romosozumab versus denosumab in high-risk patients treated with glucocorticosteroids
A phase 3 study of repeat injection of TLC599 in osteoarthritis of the knee
Please login below to download this issue (PDF)